Please login to the form below

Not currently logged in
Email:
Password:

HSDD

This page shows the latest HSDD news and features for those working in and with pharma, biotech and healthcare.

Valeant swoops on Sprout to claim female sexual disorder drug

Valeant swoops on Sprout to claim female sexual disorder drug

Comes in the same week that firm gained US approval for its ‘little pink pill’

Latest news

  • FDA approves first female sexual disorder drug FDA approves first female sexual disorder drug

    The FDA has approved the drug for generalised hypoactive sexual desire disorder (HSDD) in premenopausal women and said this is the first time that a drug has been approved for sexual

  • FDA panel backs Sprout Pharma's 'female Viagra' FDA panel backs Sprout Pharma's 'female Viagra'

    Could be approved for HSDD in pre-menopausal women. Sprout Pharmaceuticals has moved a step closer to securing approval for a drug to treat reduced libido in women after getting a ... If given the nod by the FDA, flibanserin would become the first ever

  • Lamb to the slaughter

    The Daily Telegraph ran a piece on Hypoactive Sexual Desire Disorder (HSDD), usually referred to as 'Female Sexual Dysfunction'.

  • Trials show effectiveness for HSDD

    HSDD is a medical condition characterised by a decrease in sexual desire associated with marked distress and/or interpersonal difficulties. ... Flibanserin is a novel, non-hormonal compound, that has been investigated as a treatment for pre-menopausal

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics